Bacterial folate synthesis enzyme complex (None standardized for the enzyme complex as a whole)

Bacterial folate synthesis enzymes catalyze the multi-step biosynthetic pathway that produces tetrahydrofolate (THF), an essential cofactor for one-carbon transfer reactions critical to DNA synthesis, purine and pyrimidine nucleotide production, and amino acid biosynthesis[1][3]. The pathway involves seven enzymes and three precursors (GTP, p-aminobenzoic acid, and glutamate) and is composed of distinct biosynthetic modules for pterin synthesis, para-aminobenzoate (PABA) synthesis, and their ligation to form functional folate cofactors[3][4]. Notably, the DHFR and TYMS enzymes function as an evolutionarily coupled adaptive unit; metabolomic studies show that TYMS activity must not exceed DHFR activity to prevent depletion of reduced folates and toxic accumulation of the intermediate dihydrofolate[1]. These enzymes are well-established therapeutic targets for antibiotic development, with trimethoprim inhibiting DHFR and sulfonamides targeting PABA synthesis enzymes[1][3]. However, the coupled nature of the DHFR-TYMS unit facilitates rapid emergence of antibiotic resistance through coordinated compensatory mutations, as documented in both laboratory evolution experiments and clinical trimethoprim-resistant bacterial isolates[1].

Other names

Tetrahydrofolate (THF) synthesis pathway enzymesFolate biosynthetic pathway enzymesOne-carbon metabolism enzymesDihydrofolate reductase (DHFR) and thymidylate synthase (TYMS) adaptive unit

DHFR inhibition: Blocks conversion of dihydrofolate (DHF) to tetrahydrofolate (THF), preventing one-carbon transfer reactions PABA synthesis inhibition: Sulfonamides target early steps in PABA moiety synthesis Downstream metabolite depletion: Inhibition leads to depletion of reduced folates (THF species) and accumulation of dihydrofolate, which are detrimental to cell growth